Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review.

Zhang, Zizhen; Du, Yang; Chen, Lizhi; Liu, Ying; Du, Biao

Zhang, Zizhen; Du, Yang; Chen, Lizhi; Liu, Ying; Du, Biao.

Affiliation

Zhang Z; School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Du Y; Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicineï¼Shanghai 200030ï¼China.
Chen L; School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Liu Y; School of Pharmacy, North Sichuan Medical College, Nanchong 637000, China.
Du B; Department of Pharmacy, Chongqing University Three Gorges Hospital, Chongqing 404000, China. Electronic address: 1449615818@qq.com.

Asian J Psychiatr ; 73: 103092, 2022 Jul.

Article in En | MEDLINE | ID: mdl-35430493

Subject(s)

Diabetes Mellitus, Type 2; Fluoxetine; Antidepressive Agents; Blood Glucose/metabolism; Body Weight; Fluoxetine/pharmacology; Fluoxetine/therapeutic use; Glucose; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors/pharmacology; Selective Serotonin Reuptake Inhibitors/therapeutic use

Key words

Diabetes; FBG; Fluoxetine; Glycometabolism; HbA1c; Weight

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluoxetine / Diabetes Mellitus, Type 2 Type of study: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Asian J Psychiatr Year: 2022 Document type: Article Affiliation country: China Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google